Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-046990
Filing Date
2024-11-20
Accepted
2024-11-20 16:30:06
Documents
1
Period of Report
2024-11-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4125
  Complete submission text file 0001493152-24-046990.txt   5643
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Issuer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 38 OXBERRY AVENUE LONDON X0 SW6 5SS
Business Address
Bligh James (Reporting) CIK: 0001990748 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41245 | Film No.: 241480778